Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Medton Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Suzhou Medton Pharmaceutical Technology Co., Ltd.
100 Deals associated with Suzhou Medton Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Suzhou Medton Pharmaceutical Technology Co., Ltd.